94 related articles for article (PubMed ID: 20137348)
1. [Lung adenocarcinoma stem cell phenotypes and their correlation with patient prognosis].
Zhang XY; Zheng BQ; Han BH; Huang JS; Geng Q; Xu HL; Zhou J; Dong QG
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):836-40. PubMed ID: 20137348
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of OCT4 expression in adenocarcinoma of the lung.
Zhang X; Han B; Huang J; Zheng B; Geng Q; Aziz F; Dong Q
Jpn J Clin Oncol; 2010 Oct; 40(10):961-6. PubMed ID: 20462980
[TBL] [Abstract][Full Text] [Related]
3. The expression of stem cell-related indicators as a prognostic factor in human lung adenocarcinoma.
Zhang XY; Dong QG; Huang JS; Huang AM; Shi CL; Jin B; Sha HF; Feng JX; Geng Q; Zhou J; Xu HL; Han BH
J Surg Oncol; 2010 Dec; 102(7):856-62. PubMed ID: 20818602
[TBL] [Abstract][Full Text] [Related]
4. OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention.
Karoubi G; Gugger M; Schmid R; Dutly A
Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):393-7. PubMed ID: 19126554
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-II as a prognostic factor in pulmonary adenocarcinoma.
Takanami I; Imamuma T; Hashizume T; Kikuchi K; Yamamoto Y; Yamamoto T; Kodaira S
J Surg Oncol; 1996 Mar; 61(3):205-8. PubMed ID: 8637208
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of octamer-4 expression in primary lung adenocarcinoma.
Ko TY
Asian J Surg; 2021 Jan; 44(1):425-426. PubMed ID: 33280979
[No Abstract] [Full Text] [Related]
7. microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4.
Yin R; Zhang S; Wu Y; Fan X; Jiang F; Zhang Z; Feng D; Guo X; Xu L
Oncol Rep; 2011 Jun; 25(6):1747-54. PubMed ID: 21479367
[TBL] [Abstract][Full Text] [Related]
8. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung.
Uchino K; Ito A; Wakayama T; Koma Y; Okada T; Ohbayashi C; Iseki S; Kitamura Y; Tsubota N; Okita Y; Okada M
Cancer; 2003 Sep; 98(5):1002-7. PubMed ID: 12942568
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung.
Kim YT; Park SJ; Lee SH; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1378. PubMed ID: 16256792
[TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis as a major prognostic factor in stage I lung adenocarcinoma.
Kawaguchi T; Yamamoto S; Kudoh S; Goto K; Wakasa K; Sakurai M
Anticancer Res; 1997; 17(5B):3743-6. PubMed ID: 9427772
[TBL] [Abstract][Full Text] [Related]
11. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of a solid component in pulmonary adenocarcinoma.
Ohtaki Y; Yoshida J; Ishii G; Aokage K; Hishida T; Nishimura M; Takeyoshi I; Nagai K
Ann Thorac Surg; 2011 Apr; 91(4):1051-7. PubMed ID: 21440121
[TBL] [Abstract][Full Text] [Related]
14. [Expression of HDGF and its implication in stage I non-small cell lung cancer].
Zhou SJ; Xu SF; Zhang HQ; Liu ZD
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):927-30. PubMed ID: 18478933
[TBL] [Abstract][Full Text] [Related]
15. Identification of bronchioalveolar stem cells in normal lung and lung cancer.
Kim CF; Jackson EL; Woolfenden AE; Lawrence S; Babar I; Vogel S; Crowley D; Bronson RT; Jacks T
Cell; 2005 Jun; 121(6):823-35. PubMed ID: 15960971
[TBL] [Abstract][Full Text] [Related]
16. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis.
Minami Y; Matsuno Y; Iijima T; Morishita Y; Onizuka M; Sakakibara Y; Noguchi M
Lung Cancer; 2005 Jun; 48(3):339-48. PubMed ID: 15893002
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic features of lung pleomorphic (spindle/giant cell) carcinoma--a report of 17 cases].
Zhao ZL; Song N; Huang QY; Liu YP; Zhao HR
Ai Zheng; 2007 Feb; 26(2):183-8. PubMed ID: 17298750
[TBL] [Abstract][Full Text] [Related]
18. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
20. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
Enatsu S; Yoshida J; Yokose T; Nishimura M; Nishiwaki Y; Shirakusa T; Nagai K
Ann Thorac Surg; 2006 Jan; 81(1):298-304. PubMed ID: 16368385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
